Sign inJoin waitlistJoin the waitlist

Shlomo Koyfman

Assistant Professor, Department of Medicine, School of Medicine · Case Western Reserve University

Credentials: · · ·

History

Case Western Reserve University
Present

Radiation Oncology
Cleveland Clinic Foundation
2007–2011
Radiology-Diagnostic
Cleveland Clinic
2006–2011
Yale Univ Sch of Med
2002–2006
Yeshiva University
1998–2002

Research

Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial
The Lancet · 2019 · 1,066 citations
Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a…
The Lancet Oncology · 2016 · 582 citations
Management of the Neck in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx: ASCO Clinical Practice Guideline
Journal of Clinical Oncology · 2019 · First of 12 authors · 297 citations

Neil Woody
53 papers · 6 as a resident
David Adelstein
48 papers
Allison Vidimos
47 papers
Brian Burkey
46 papers
Eric Lamarre
41 papers
Joseph Scharpf
41 papers
Emily Ruiz
40 papers
Jessica Geiger
39 papers · 2 as a fellow
Nikhil Joshi
37 papers · 27 as a resident
Brandon Prendes
34 papers · 1 as a fellow
Matthew Ward
32 papers · 18 as a resident
Ashley Wysong
25 papers

Grants

Quantitative Histomorphometric Risk Classifier (QuHbIC) in HPV + Oropharyngeal Carcinoma
National Cancer Institute · R01
Contact PI · $1.2M · Case Western Reserve University
2018–2025

Clinical trials

The Addition of Pembrolizumab to Postoperative Radiotherapy in Cutaneous Squamous Cell Cancer of the Head and Neck
Principal investigator · Completed · Phase 2
Case Comprehensive Cancer Center
2017–2020
Stereotactic Body Radiation Therapy in Treating Patients With High Risk Locally Advanced Head and Neck Cancer
Principal investigator · Terminated
Case Comprehensive Cancer Center
2015–2017
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
Site PI · Recruiting
Tempus AI
2024–2028